Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Endocrinology and Metabolism
>
2012
>
28
>
9
Volume:
28
Issue:
9
1. Approach to the patient with primary hypothyroidism accompanied by pituitary hyperplasia and increased serum creatine kinase level
Page:761—764
2. Study on induction of immunotolerance against Graves' disease in neonatal mice
Page:744—749
3. Expression of macrophage migration inhibitory factor in peripheral blood of patients with Hashimoto's thyroiditis and its clinical significance
Page:741—743
4. Satisfaction and usability of SoloStar(R) in diabetic patients from China——SUPERSTAR Study
Page:715—719
5. On the relationship between the change in waist circumference and new onset of diabetes: Study on a population of Northern China
Page:710—714
6. Study on the distinction of glycemic variability among different glucose regulation populations by phase space reconstruction of time series
Page:722—725
7. Study on the related risk factors with atherogenic index of plasma in male type 2 diabetic patients
Page:720—722
8. Metabolism of amino acids and type 2 diabetes mellitus
Page:773—776
9. Effects of metformin on chemerin expression in visceral adipose tissue of insulin-resistant rats
Page:757—760
10. The influence of purine content in diet on serum uric acid of old males
Page:734—737
11. Clinical characteristics and diagnostic analysis of thyrotropinoma
Page:729—733
12. Fibrinogen is a predictor for progressive proteinuria in type 2 diabetes
Page:726—728
13. Inheritance, innovation, and initiative——An annual review of diabetic researches in Shanghai
Page:695—699
14. AMP-activated protein kinase inhibits KiSS-1 gene expression through SP1 in the hypothalamic GT1-7 neurons
Page:754—757
15. Effect of propylthiouracil and methimazole on serum cytokines in patients with Graves' disease
Page:737—740
16. Update on the research of diabetic dyslipidemia
Page:704—709
17. Comparison of incretin-based drugs: clinical advantage of GLP-1 analogue liraglutide
Page:后插8—后插11
18. Comparison of glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mettilus
Page:后插1—后插7